Different Exercise Modalities in Chronic Kidney Disease: A Longitudinal Intervention Study

Ki vehet részt

• <p style="line-height: 2.5;">
• Aged 30-60 years, of either sex
• Meets the CKD diagnostic criteria in the Kidney Disease: Improving Global Outcomes (KDIGO) guidance and the 2023 Expert Recommendations on the Clinical Pathway for Early Screening of Chronic Kidney Disease (CKD) and Its Complications in Chinese Adults. Two categories of participants will be included: individuals with early-stage CKD, stages G1 and G2, with an estimated glomerular filtration rate (eGFR) of 60-90 mL/min/1.73 m²; and individuals with established CKD, stages G3 and G4, with an eGFR of 15-59 mL/min/1.73 m², who have been assessed by a clinician as able to participate in exercise
• Clinically stable, with no dialysis or kidney transplantation within the previous six months
• No severe cardiopulmonary dysfunction or other contraindications to exercise
• Sufficient cognitive ability to comply with the intervention plan
• Willing to participate in the study and provide written informed consent. </p>

Ki nem vehet részt

• Participation in another clinical trial or structured exercise intervention program within the previous three months
• Acute kidney failure; severe hypertension (above 180/110 mmHg); diabetes; heart failure; acute infection; malignancy; or active immune disease
• Severe edema, musculoskeletal disease, or other conditions that prevent participation in exercise
• Severe cognitive impairment or inability to cooperate with the study. </p>
• <p style="line-height: 2.5;">
• Body mass index (BMI)≥35 kg/m²
• Pregnancy or plans to become pregnant